Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In vitro analyses, animal models, and 60 clinical cases of invasive Aspergillus terreus infection.

Literature DB >> 15328076

In vitro analyses, animal models, and 60 clinical cases of invasive Aspergillus terreus infection.

William J Steinbach¹, John R Perfect, Wiley A Schell, Thomas J Walsh, Daniel K Benjamin.

Abstract

Entities: Disease

Mesh：

Substances：
Antifungal Agents

Year: 2004 PMID： 15328076 PMCID： PMC514747 DOI： 10.1128/AAC.48.9.3217-3225.2004

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

× No keyword cloud information.

100 in total

1. In vitro activities of terbinafine against Aspergillus species in comparison with those of itraconazole and amphotericin B.

Authors: C B Moore; C M Walls; D W Denning
Journal: Antimicrob Agents Chemother Date: 2001-06 Impact factor: 5.191

2. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.

Authors: A Espinel-Ingroff
Journal: J Clin Microbiol Date: 2001-03 Impact factor: 5.948

Review 3. Clinical significance of Aspergillus fungaemia in patients with haematological malignancies and invasive aspergillosis.

Authors: C Girmenia; M Nucci; P Martino
Journal: Br J Haematol Date: 2001-07 Impact factor: 6.998

4. The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis.

Authors: J R Perfect; G M Cox; J Y Lee; C A Kauffman; L de Repentigny; S W Chapman; V A Morrison; P Pappas; J W Hiemenz; D A Stevens
Journal: Clin Infect Dis Date: 2001-10-22 Impact factor: 9.079

5. Colorimetric assay for antifungal susceptibility testing of Aspergillus species.

Authors: J Meletiadis; J W Mouton; J F Meis; B A Bouman; J P Donnelly; P E Verweij
Journal: J Clin Microbiol Date: 2001-09 Impact factor: 5.948

6. In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates.

Authors: S Arikan; M Lozano-Chiu; V Paetznick; J H Rex
Journal: Antimicrob Agents Chemother Date: 2001-01 Impact factor: 5.191

7. Synergy, pharmacodynamics, and time-sequenced ultrastructural changes of the interaction between nikkomycin Z and the echinocandin FK463 against Aspergillus fumigatus.

Authors: C C Chiou; N Mavrogiorgos; E Tillem; R Hector; T J Walsh
Journal: Antimicrob Agents Chemother Date: 2001-12 Impact factor: 5.191

8. Nosocomial invasive aspergillosis in lymphoma patients treated with bone marrow or peripheral stem cell transplants.

Authors: P C Iwen; E C Reed; J O Armitage; P J Bierman; A Kessinger; J M Vose; M A Arneson; B A Winfield; G L Woods
Journal: Infect Control Hosp Epidemiol Date: 1993-03 Impact factor: 3.254

Review 9. In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature.

Authors: A Espinel-Ingroff; K Boyle; D J Sheehan
Journal: Mycopathologia Date: 2001 Impact factor: 3.785

10. Fungal discitis due to Aspergillus terreus in a patient with acute lymphoblastic leukemia.

Authors: K U Park; H S Lee; C J Kim; E C Kim
Journal: J Korean Med Sci Date: 2000-12 Impact factor: 2.153

33 in total

1. Efficacy of caspofungin against Aspergillus terreus.

Authors: Francesco Barchiesi; Elisabetta Spreghini; Alfredo Santinelli; Annette W Fothergill; Stefania Fallani; Esther Manso; Eleonora Pisa; Daniele Giannini; Andrea Novelli; Maria I Cassetta; Teresita Mazzei; Michael G Rinaldi; Giorgio Scalise
Journal: Antimicrob Agents Chemother Date: 2005-12 Impact factor: 5.191

2. In vitro activities of amphotericin B and voriconazole against aleurioconidia from Aspergillus terreus.

Authors: Cornelia Lass-Flörl; Alexandra Rief; Sandra Leitner; Cornelia Speth; Reinhard Würzner; Manfred P Dierich
Journal: Antimicrob Agents Chemother Date: 2005-06 Impact factor: 5.191

3. Time of incubation for antifungal susceptibility testing of Aspergillus fumigatus: can MIC values be obtained at 24 hours?

Authors: Juan Luis Rodriguez-Tudela; Laura Alcazar-Fuoli; Ana Alastruey-Izquierdo; Araceli Monzon; Emilia Mellado; Manuel Cuenca-Estrella
Journal: Antimicrob Agents Chemother Date: 2007-10-15 Impact factor: 5.191

4. In vitro activities of various antifungal drugs against Aspergillus terreus: Global assessment using the methodology of the European committee on antimicrobial susceptibility testing.

Authors: Cornelia Lass-Flörl; Ana Alastruey-Izquierdo; Manuel Cuenca-Estrella; Susanne Perkhofer; Juan Luis Rodriguez-Tudela
Journal: Antimicrob Agents Chemother Date: 2008-12-08 Impact factor: 5.191

5. Polyphasic identification and susceptibility to seven antifungals of 102 Aspergillus isolates recovered from immunocompromised hosts in Greece.

Authors: Michael Arabatzis; Manousos Kambouris; Miltiades Kyprianou; Aikaterini Chrysaki; Maria Foustoukou; Maria Kanellopoulou; Lydia Kondyli; Georgia Kouppari; Chrysa Koutsia-Karouzou; Evangelia Lebessi; Anastasia Pangalis; Efthimia Petinaki; Ageliki Stathi; Eleftheria Trikka-Graphakos; Erriketi Vartzioti; Aliki Vogiatzi; Timoleon-Achilleas Vyzantiadis; Loukia Zerva; Aristea Velegraki
Journal: Antimicrob Agents Chemother Date: 2011-03-28 Impact factor: 5.191

6. In vitro activity and in vivo efficacy of posaconazole in treatment of murine infections by different isolates of the Aspergillus terreus complex.

Authors: Valentina Salas; F Javier Pastor; M M Rodríguez; Enrique Calvo; Emilio Mayayo; Josep Guarro
Journal: Antimicrob Agents Chemother Date: 2010-11-29 Impact factor: 5.191

7. Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant-Associated Infection Surveillance Network.

Authors: John W Baddley; Kieren A Marr; David R Andes; Thomas J Walsh; Carol A Kauffman; Dimitrios P Kontoyiannis; James I Ito; S Arunmozhi Balajee; Peter G Pappas; Stephen A Moser
Journal: J Clin Microbiol Date: 2009-08-19 Impact factor: 5.948